|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows provided by (used in) operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Provision for credit losses | |||||
| Amortization of intangible assets | |||||
| Amortization of mortgage servicing rights | |||||
| Amortization of New Markets Tax Credit | |||||
| Depreciation and amortization of premises and equipment | |||||
| Net amortization (accretion) on portfolio loans | |||||
| Net amortization (accretion) of premium (discount) on investment securities | |||||
| Net amortization (accretion) of premium (discount) on time deposits | |||||
| Net amortization (accretion) of premium (discount) on FHLB advances and other borrowings | |||||
| Impairment of OREO and other repossessed assets | |||||
| Impairment of fixed assets held for sale | |||||
| Impairment of mortgage servicing rights | |||||
| Impairment of leases | |||||
| Unrealized (gains) losses recognized on equity securities, net | |||||
| (Gain) loss on sales of equity securities, net | |||||
| (Gain) loss on sales of debt securities, net | |||||
| (Gain) loss on sales of mortgage servicing rights | |||||
| (Gain) loss on sales of loans, net | |||||
| (Gain) loss on sales of OREO and other repossessed assets | |||||
| (Gain) loss on sales of premises and equipment | |||||
| (Gain) loss on life insurance proceeds | |||||
| Increase in cash surrender value of bank owned life insurance | |||||
| Provision for deferred income taxes | |||||
| Stock-based compensation | |||||
| Proceeds from the sale of mortgage servicing rights | |||||
| Mortgage loans originated for sale | |||||
| Proceeds from sales of mortgage loans | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows provided by (used in) investing activities | |||||
| Purchases of equity securities | |||||
| Purchases of debt securities available for sale | |||||
| Proceeds from sales of equity securities | |||||
| Proceeds from sales of debt securities available for sale | |||||
| Proceeds from paydowns and maturities of debt securities held to maturity | |||||
| Proceeds from paydowns and maturities of debt securities available for sale | |||||
| Purchases of restricted bank stock | |||||
| Proceeds from the redemption of restricted bank stock | |||||
| Purchases of loans | |||||
| Net decrease in loans | |||||
| Net cash received in acquisitions (see Note 2) | |||||
| Cash paid for premiums on bank-owned life insurance | |||||
| Proceeds from life insurance | |||||
| Purchases of premises and equipment | |||||
| Proceeds from disposition of premises and equipment | |||||
| Net proceeds from OREO and other repossessed assets | |||||
| Net cash provided by investing activities | |||||
| Cash flows provided by (used in) financing activities | |||||
| Net increase (decrease) in deposits | |||||
| Net increase (decrease) in federal funds purchased and securities sold under agreements to repurchase | |||||
| Proceeds from short-term borrowings | |||||
| Repayment of short-term borrowings | |||||
| Proceeds from other borrowings, net of debt issuance costs | |||||
| Repayment of other borrowings | |||||
| Cash dividends paid | |||||
| Purchase of treasury stock | |||||
| Cash paid for withholding taxes on stock-based payments | |||||
| Proceeds from stock options exercised | |||||
| Proceeds from stock warrants exercised | |||||
| Proceeds from (cash paid for) the exercise of stock options, warrants, and SSARs | |||||
| Issuance of treasury stock for the ESPP | |||||
| Issuance of preferred stock, net of stock issuance costs | |||||
| Common stock issuance costs | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, ending of period | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | |||||
| Cash payments for: | |||||
| Interest | |||||
| Income taxes | |||||
| Non-cash investing and financing activities: | |||||
| OREO and other repossessed assets acquired in settlement of loans | |||||
| Transfer of debt securities available for sale to held to maturity | |||||
| Transfer of loans held for sale to portfolio loans | |||||
Loading...
